Physical Therapy Department, Multiple Sclerosis Foundation, Madrid, Spain.
Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine Department, Faculty of Health Sciences, Rey Juan Carlos University, Madrid, Spain.
PM R. 2021 Mar;13(3):307-313. doi: 10.1002/pmrj.12423. Epub 2020 Jul 27.
In clinical practice, observational scales are the most common approach used to assess gait pattern in people with neurological disorders. The Gait Assessment and Intervention Tool (GAIT) is an observational gait scale, and it has proved to be the most comprehensive, homogeneous, and objective of all the observational gait scales studied in people with neurological conditions.
To study the construct validity of the GAIT in people with multiple sclerosis (MS).
An observational study was conducted.
Multiple Sclerosis Foundation in Madrid (Spain).
Thirty-five patients with MS were assessed.
MAIN OUTCOME MEASURE(S): GAIT construct validity was assessed using the following scales: Rivermead Visual Gait Assessment (RVGA), Tinetti Gait Scale (TGS), 10-Meter Walking Test (10MWT), Timed Up&Go (TUG), Hauser Ambulatory Index (HAI), Multiple Sclerosis Walking Scale-12 (MSWS-12), Functional Gait Assessment (FGA), Modified Ashworth Scale (MAS), and Rivermead Mobility Index (RMI).
A total of 35 subjects with MS were assessed. The correlations between the GAIT and the RVGA were excellent (r > .90) and moderate with TGS (values between -.62 and -.59). Correlations with HAI, FGA, MSWS-12, and RMI were moderate (with values between .57 and .67). Correlations were lower for the velocity scales TUG and MAS.
The construct validity of the GAIT is high, as a measure of gait coordination in people with MS. Specifically, there was excellent correlation with the RVGA. There was a moderate correlation for the GAIT with measures of functional mobility, but a lesser correlation of the GAIT with measures restricted to temporal gait characteristics (speed measures) or measurements of impairments underlying gait patterns such as balance or muscle tone.
在临床实践中,观察量表是评估神经障碍患者步态模式最常用的方法。步态评估和干预工具(GAIT)是一种观察性步态量表,已被证明是所有研究神经疾病患者的观察性步态量表中最全面、最同质、最客观的量表。
研究 GAIT 在多发性硬化症(MS)患者中的结构效度。
观察性研究。
马德里多发性硬化症基金会(西班牙)。
35 名 MS 患者接受评估。
使用以下量表评估 GAIT 的结构效度:Rivermead 视觉步态评估(RVGA)、Tinetti 步态量表(TGS)、10 米步行测试(10MWT)、计时起立行走测试(TUG)、豪泽活动指数(HAI)、多发性硬化症步行量表-12(MSWS-12)、功能性步态评估(FGA)、改良 Ashworth 量表(MAS)和 Rivermead 移动指数(RMI)。
共评估了 35 名 MS 患者。GAIT 与 RVGA 的相关性非常好(r>.90),与 TGS 的相关性为中度(-62 至-.59)。与 HAI、FGA、MSWS-12 和 RMI 的相关性为中度(.57 至.67)。TUG 和 MAS 的速度量表相关性较低。
GAIT 的结构效度较高,可作为评估 MS 患者步态协调性的指标。特别是与 RVGA 的相关性非常好。GAIT 与功能性移动性测量指标具有中度相关性,但与仅限制于时间步态特征(速度测量)或与步态模式相关的障碍测量(如平衡或肌肉张力)的 GAIT 相关性较低。